Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Sartans are a group of pharmaceuticals that modulate the renin–angiotensin system. Their main uses are in the treatment of hypertension (high blood pressure), diabetic nephropathy (kidney damage due to diabetes) and congestive heart failure. They block the activation of AT1receptors, preventing the binding of angiotensin II.
This report offers an overview of the market trends, drivers, and barriers with respect to the China Sartans market. It also provides a detailed overview of the market of different regions across North China, Central China, South China, East China, Northeast China, Southwest China, Northwest China. The report deep analyzes type and application in China Sartans market. Detailed analysis of key players, along with key growth strategies adopted by Sartans industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Merck
Bayer
Pfizer
Teva Pharmaceutical
Astra Zeneca
Bristol-Myers Squibb
GSK
Jhonson and Johnson
Eli Lilly and Company
Sanofi SA
Novartis
By Type:
Valsartan
Telmisartan
Losartan
Irbesartan
Azilsartan
Olmesartan
By End-User:
Hypertension
Cardiovascular Diseases
Kidney Diseases
Other
By Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Sartans Market
-
1.3 Market Segment by Type
-
1.3.1 China Sartans Market Size and Growth Rate of Valsartan from 2016 to 2027
-
1.3.2 China Sartans Market Size and Growth Rate of Telmisartan from 2016 to 2027
-
1.3.3 China Sartans Market Size and Growth Rate of Losartan from 2016 to 2027
-
1.3.4 China Sartans Market Size and Growth Rate of Irbesartan from 2016 to 2027
-
1.3.5 China Sartans Market Size and Growth Rate of Azilsartan from 2016 to 2027
-
1.3.6 China Sartans Market Size and Growth Rate of Olmesartan from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 China Sartans Market Size and Growth Rate of Hypertension from 2016 to 2027
-
1.4.2 China Sartans Market Size and Growth Rate of Cardiovascular Diseases from 2016 to 2027
-
1.4.3 China Sartans Market Size and Growth Rate of Kidney Diseases from 2016 to 2027
-
1.4.4 China Sartans Market Size and Growth Rate of Other from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 North China Sartans Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 Central China Sartans Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 South China Sartans Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 East China Sartans Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.5 Northeast China Sartans Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.6 Southwest China Sartans Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.7 Northwest China Sartans Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Sartans Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Commercial Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Sartans by Major Types
-
3.4.1 Market Size and Growth Rate of Valsartan
-
3.4.2 Market Size and Growth Rate of Telmisartan
-
3.4.3 Market Size and Growth Rate of Losartan
-
3.4.4 Market Size and Growth Rate of Irbesartan
-
3.4.5 Market Size and Growth Rate of Azilsartan
-
3.4.6 Market Size and Growth Rate of Olmesartan
4 Segmentation of Sartans Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Sartans by Major End-Users
-
4.4.1 Market Size and Growth Rate of Sartans in Hypertension
-
4.4.2 Market Size and Growth Rate of Sartans in Cardiovascular Diseases
-
4.4.3 Market Size and Growth Rate of Sartans in Kidney Diseases
-
4.4.4 Market Size and Growth Rate of Sartans in Other
5 Market Analysis by Regions
-
5.1 China Sartans Production Analysis by Regions
-
5.2 China Sartans Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on China Economy
6 North China Sartans Landscape Analysis
-
6.1 North China Sartans Landscape Analysis by Major Types
-
6.2 North China Sartans Landscape Analysis by Major End-Users
7 Central China Sartans Landscape Analysis
-
7.1 Central China Sartans Landscape Analysis by Major Types
-
7.2 Central China Sartans Landscape Analysis by Major End-Users
8 South China Sartans Landscape Analysis
-
8.1 South China Sartans Landscape Analysis by Major Types
-
8.2 South China Sartans Landscape Analysis by Major End-Users
9 East China Sartans Landscape Analysis
-
9.1 East China Sartans Landscape Analysis by Major Types
-
9.2 East China Sartans Landscape Analysis by Major End-Users
10 Northeast China Sartans Landscape Analysis
-
10.1 Northeast China Sartans Landscape Analysis by Major Types
-
10.2 Northeast China Sartans Landscape Analysis by Major End-Users
11 Southwest China Sartans Landscape Analysis
-
11.1 Southwest China Sartans Landscape Analysis by Major Types
-
11.2 Southwest China Sartans Landscape Analysis by Major End-Users
12 Northwest China Sartans Landscape Analysis
-
12.1 Northwest China Sartans Landscape Analysis by Major Types
-
12.2 Northwest China Sartans Landscape Analysis by Major End-Users
13 Major Players Profiles
-
13.1 Merck
-
13.1.1 Merck Company Profile and Recent Development
-
13.1.2 Market Performance
-
13.1.3 Product and Service Introduction
-
13.2 Bayer
-
13.2.1 Bayer Company Profile and Recent Development
-
13.2.2 Market Performance
-
13.2.3 Product and Service Introduction
-
13.3 Pfizer
-
13.3.1 Pfizer Company Profile and Recent Development
-
13.3.2 Market Performance
-
13.3.3 Product and Service Introduction
-
13.4 Teva Pharmaceutical
-
13.4.1 Teva Pharmaceutical Company Profile and Recent Development
-
13.4.2 Market Performance
-
13.4.3 Product and Service Introduction
-
13.5 Astra Zeneca
-
13.5.1 Astra Zeneca Company Profile and Recent Development
-
13.5.2 Market Performance
-
13.5.3 Product and Service Introduction
-
13.6 Bristol-Myers Squibb
-
13.6.1 Bristol-Myers Squibb Company Profile and Recent Development
-
13.6.2 Market Performance
-
13.6.3 Product and Service Introduction
-
13.7 GSK
-
13.7.1 GSK Company Profile and Recent Development
-
13.7.2 Market Performance
-
13.7.3 Product and Service Introduction
-
13.8 Jhonson and Johnson
-
13.8.1 Jhonson and Johnson Company Profile and Recent Development
-
13.8.2 Market Performance
-
13.8.3 Product and Service Introduction
-
13.9 Eli Lilly and Company
-
13.9.1 Eli Lilly and Company Company Profile and Recent Development
-
13.9.2 Market Performance
-
13.9.3 Product and Service Introduction
-
13.10 Sanofi SA
-
13.10.1 Sanofi SA Company Profile and Recent Development
-
13.10.2 Market Performance
-
13.10.3 Product and Service Introduction
-
13.11 Novartis
-
13.11.1 Novartis Company Profile and Recent Development
-
13.11.2 Market Performance
-
13.11.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure China Sartans Market Size and Growth Rate of Valsartan from 2016 to 2027
-
Figure China Sartans Market Size and Growth Rate of Telmisartan from 2016 to 2027
-
Figure China Sartans Market Size and Growth Rate of Losartan from 2016 to 2027
-
Figure China Sartans Market Size and Growth Rate of Irbesartan from 2016 to 2027
-
Figure China Sartans Market Size and Growth Rate of Azilsartan from 2016 to 2027
-
Figure China Sartans Market Size and Growth Rate of Olmesartan from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2021
-
Figure Market Share by Type in 2027
-
Figure China Sartans Market Size and Growth Rate of Hypertension from 2016 to 2027
-
Figure China Sartans Market Size and Growth Rate of Cardiovascular Diseases from 2016 to 2027
-
Figure China Sartans Market Size and Growth Rate of Kidney Diseases from 2016 to 2027
-
Figure China Sartans Market Size and Growth Rate of Other from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2021
-
Figure Market Share by End-User in 2027
-
Figure North China Sartans Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Central China Sartans Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South China Sartans Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure East China Sartans Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast China Sartans Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Southwest China Sartans Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northwest China Sartans Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Sartans Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2020
-
Figure Market Share of TOP 5 Players in 2021
-
Figure Market Share of TOP 6 Players from 2016 to 2021
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Map of China
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Sartans
-
Figure Development Trends of Different Types
-
Table Commercial Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Sartans by Different Types from 2016 to 2027
-
Table Consumption Share of Sartans by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Valsartan
-
Figure Market Size and Growth Rate of Telmisartan
-
Figure Market Size and Growth Rate of Losartan
-
Figure Market Size and Growth Rate of Irbesartan
-
Figure Market Size and Growth Rate of Azilsartan
-
Figure Market Size and Growth Rate of Olmesartan
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Sartans by Different End-Users from 2016 to 2027
-
Table Consumption Share of Sartans by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Hypertension
-
Figure Market Size and Growth Rate of Cardiovascular Diseases
-
Figure Market Size and Growth Rate of Kidney Diseases
-
Figure Market Size and Growth Rate of Other
-
Table China Sartans Production by Regions
-
Table China Sartans Production Share by Regions
-
Figure China Sartans Production Share by Regions in 2016
-
Figure China Sartans Production Share by Regions in 2021
-
Figure China Sartans Production Share by Regions in 2027
-
Table China Sartans Consumption by Regions
-
Table China Sartans Consumption Share by Regions
-
Figure China Sartans Consumption Share by Regions in 2016
-
Figure China Sartans Consumption Share by Regions in 2021
-
Figure China Sartans Consumption Share by Regions in 2027
-
Table North China Sartans Consumption by Types from 2016 to 2027
-
Table North China Sartans Consumption Share by Types from 2016 to 2027
-
Figure North China Sartans Consumption Share by Types in 2016
-
Figure North China Sartans Consumption Share by Types in 2021
-
Figure North China Sartans Consumption Share by Types in 2027
-
Table North China Sartans Consumption by End-Users from 2016 to 2027
-
Table North China Sartans Consumption Share by End-Users from 2016 to 2027
-
Figure North China Sartans Consumption Share by End-Users in 2016
-
Figure North China Sartans Consumption Share by End-Users in 2021
-
Figure North China Sartans Consumption Share by End-Users in 2027
-
Table Central China Sartans Consumption by Types from 2016 to 2027
-
Table Central China Sartans Consumption Share by Types from 2016 to 2027
-
Figure Central China Sartans Consumption Share by Types in 2016
-
Figure Central China Sartans Consumption Share by Types in 2021
-
Figure Central China Sartans Consumption Share by Types in 2027
-
Table Central China Sartans Consumption by End-Users from 2016 to 2027
-
Table Central China Sartans Consumption Share by End-Users from 2016 to 2027
-
Figure Central China Sartans Consumption Share by End-Users in 2016
-
Figure Central China Sartans Consumption Share by End-Users in 2021
-
Figure Central China Sartans Consumption Share by End-Users in 2027
-
Table South China Sartans Consumption by Types from 2016 to 2027
-
Table South China Sartans Consumption Share by Types from 2016 to 2027
-
Figure South China Sartans Consumption Share by Types in 2016
-
Figure South China Sartans Consumption Share by Types in 2021
-
Figure South China Sartans Consumption Share by Types in 2027
-
Table South China Sartans Consumption by End-Users from 2016 to 2027
-
Table South China Sartans Consumption Share by End-Users from 2016 to 2027
-
Figure South China Sartans Consumption Share by End-Users in 2016
-
Figure South China Sartans Consumption Share by End-Users in 2021
-
Figure South China Sartans Consumption Share by End-Users in 2027
-
Table East China Sartans Consumption by Types from 2016 to 2027
-
Table East China Sartans Consumption Share by Types from 2016 to 2027
-
Figure East China Sartans Consumption Share by Types in 2016
-
Figure East China Sartans Consumption Share by Types in 2021
-
Figure East China Sartans Consumption Share by Types in 2027
-
Table East China Sartans Consumption by End-Users from 2016 to 2027
-
Table East China Sartans Consumption Share by End-Users from 2016 to 2027
-
Figure East China Sartans Consumption Share by End-Users in 2016
-
Figure East China Sartans Consumption Share by End-Users in 2021
-
Figure East China Sartans Consumption Share by End-Users in 2027
-
Table Northeast China Sartans Consumption by Types from 2016 to 2027
-
Table Northeast China Sartans Consumption Share by Types from 2016 to 2027
-
Figure Northeast China Sartans Consumption Share by Types in 2016
-
Figure Northeast China Sartans Consumption Share by Types in 2021
-
Figure Northeast China Sartans Consumption Share by Types in 2027
-
Table Northeast China Sartans Consumption by End-Users from 2016 to 2027
-
Table Northeast China Sartans Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast China Sartans Consumption Share by End-Users in 2016
-
Figure Northeast China Sartans Consumption Share by End-Users in 2021
-
Figure Northeast China Sartans Consumption Share by End-Users in 2027
-
Table Southwest China Sartans Consumption by Types from 2016 to 2027
-
Table Southwest China Sartans Consumption Share by Types from 2016 to 2027
-
Figure Southwest China Sartans Consumption Share by Types in 2016
-
Figure Southwest China Sartans Consumption Share by Types in 2021
-
Figure Southwest China Sartans Consumption Share by Types in 2027
-
Table Southwest China Sartans Consumption by End-Users from 2016 to 2027
-
Table Southwest China Sartans Consumption Share by End-Users from 2016 to 2027
-
Figure Southwest China Sartans Consumption Share by End-Users in 2016
-
Figure Southwest China Sartans Consumption Share by End-Users in 2021
-
Figure Southwest China Sartans Consumption Share by End-Users in 2027
-
Table Northwest China Sartans Consumption by Types from 2016 to 2027
-
Table Northwest China Sartans Consumption Share by Types from 2016 to 2027
-
Figure Northwest China Sartans Consumption Share by Types in 2016
-
Figure Northwest China Sartans Consumption Share by Types in 2021
-
Figure Northwest China Sartans Consumption Share by Types in 2027
-
Table Northwest China Sartans Consumption by End-Users from 2016 to 2027
-
Table Northwest China Sartans Consumption Share by End-Users from 2016 to 2027
-
Figure Northwest China Sartans Consumption Share by End-Users in 2016
-
Figure Northwest China Sartans Consumption Share by End-Users in 2021
-
Figure Northwest China Sartans Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Merck
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck
-
Figure Sales and Growth Rate Analysis of Merck
-
Figure Revenue and Market Share Analysis of Merck
-
Table Product and Service Introduction of Merck
-
Table Company Profile and Development Status of Bayer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bayer
-
Figure Sales and Growth Rate Analysis of Bayer
-
Figure Revenue and Market Share Analysis of Bayer
-
Table Product and Service Introduction of Bayer
-
Table Company Profile and Development Status of Pfizer
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Pfizer
-
Figure Sales and Growth Rate Analysis of Pfizer
-
Figure Revenue and Market Share Analysis of Pfizer
-
Table Product and Service Introduction of Pfizer
-
Table Company Profile and Development Status of Teva Pharmaceutical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical
-
Figure Sales and Growth Rate Analysis of Teva Pharmaceutical
-
Figure Revenue and Market Share Analysis of Teva Pharmaceutical
-
Table Product and Service Introduction of Teva Pharmaceutical
-
Table Company Profile and Development Status of Astra Zeneca
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Astra Zeneca
-
Figure Sales and Growth Rate Analysis of Astra Zeneca
-
Figure Revenue and Market Share Analysis of Astra Zeneca
-
Table Product and Service Introduction of Astra Zeneca
-
Table Company Profile and Development Status of Bristol-Myers Squibb
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Bristol-Myers Squibb
-
Figure Sales and Growth Rate Analysis of Bristol-Myers Squibb
-
Figure Revenue and Market Share Analysis of Bristol-Myers Squibb
-
Table Product and Service Introduction of Bristol-Myers Squibb
-
Table Company Profile and Development Status of GSK
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of GSK
-
Figure Sales and Growth Rate Analysis of GSK
-
Figure Revenue and Market Share Analysis of GSK
-
Table Product and Service Introduction of GSK
-
Table Company Profile and Development Status of Jhonson and Johnson
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Jhonson and Johnson
-
Figure Sales and Growth Rate Analysis of Jhonson and Johnson
-
Figure Revenue and Market Share Analysis of Jhonson and Johnson
-
Table Product and Service Introduction of Jhonson and Johnson
-
Table Company Profile and Development Status of Eli Lilly and Company
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eli Lilly and Company
-
Figure Sales and Growth Rate Analysis of Eli Lilly and Company
-
Figure Revenue and Market Share Analysis of Eli Lilly and Company
-
Table Product and Service Introduction of Eli Lilly and Company
-
Table Company Profile and Development Status of Sanofi SA
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sanofi SA
-
Figure Sales and Growth Rate Analysis of Sanofi SA
-
Figure Revenue and Market Share Analysis of Sanofi SA
-
Table Product and Service Introduction of Sanofi SA
-
Table Company Profile and Development Status of Novartis
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Novartis
-
Figure Sales and Growth Rate Analysis of Novartis
-
Figure Revenue and Market Share Analysis of Novartis
-
Table Product and Service Introduction of Novartis
-
